Does PTEN loss impair DNA double-strand break repair by homologous recombination?

Clin Cancer Res. 2012 Feb 15;18(4):920-2. doi: 10.1158/1078-0432.CCR-11-3131. Epub 2011 Dec 16.

Abstract

The tumor suppressor PTEN is frequently lost in cancer cells, resulting in altered radiation and drug sensitivity. However, the role of PTEN in DNA repair is controversial. Detailed studies in prostate cancer cells now indicate PTEN does not regulate RAD51 expression or homologous recombination and is not a biomarker for PARP inhibitor sensitivity.

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Animals
  • Gene Deletion*
  • Humans
  • Male
  • PTEN Phosphohydrolase / genetics*
  • Prostatic Neoplasms / enzymology*
  • Prostatic Neoplasms / genetics*
  • Rad51 Recombinase / metabolism*

Substances

  • Rad51 Recombinase
  • PTEN Phosphohydrolase